StonvexLoading…
StonvexStonvexStonvexCore line items from SPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $457.55M | $405.91M | $333.64M | $253.83M |
Operating Income | $-43.45M | $-60.36M | $-69.28M | $-51.68M |
Net Income | $-43.33M | $-61.97M | $-66.43M | $-50.24M |
EPS (Diluted) | $-0.74 | $-1.09 | $-1.19 | $-0.92 |
Total Assets | $523.06M | $428.34M | $396.58M | $293.92M |
Total Liabilities | $319.64M | $261.75M | $252.39M | $151.58M |
Cash & Equivalents | $95.27M | $86.44M | $49.76M | $79.92M |
Free Cash Flow OCF − CapEx | $39.32M | $23.37M | $4.38M | $8.84M |
Shares Outstanding | 58.63M | 56.94M | 55.66M | 54.61M |